LENZ vs BIIB: Which Stock is Better?
Side-by-side comparison of Lenz Therapeutics Inc and Biogen Inc in 2026
LENZ
Lenz Therapeutics Inc
$10.18
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | LENZ | BIIB | Winner |
|---|---|---|---|
| Market Cap | $319.19M | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 97.8% | 78.9% | LENZ |
Analyze LENZ
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LENZ or BIIB a better investment?
Comparing LENZ and BIIB: Lenz Therapeutics Inc has a market cap of $319.19M while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LENZ and BIIB?
LENZ (Lenz Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LENZ or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LENZ or BIIB?
LENZ has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: LENZ or BIIB?
Lenz Therapeutics Inc (LENZ) has higher gross margins at 97.8% compared to 78.9% for BIIB.
Which is the larger company: LENZ or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $319.19M for LENZ.
Should I buy LENZ or BIIB in 2026?
Both LENZ and BIIB have investment merit. LENZ trades at $10.18 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LENZ and BIIB stock?
Key differences: Market Cap ($319.19M vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.0% vs -0.1%), Gross Margin (97.8% vs 78.9%).